Literature DB >> 25227143

Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations.

Burcu Bakir-Gungor1, Elaine F Remmers2, Akira Meguro3, Nobuhisa Mizuki3, Daniel L Kastner2, Ahmet Gul4, Osman U Sezerman5.   

Abstract

Behçet's disease (BD) is a multi-system inflammatory disorder of unknown etiology. Two recent genome-wide association studies (GWASs) of BD confirmed a strong association with the MHC class I region and identified two non-HLA common genetic variations. In complex diseases, multiple factors may target different sets of genes in the same pathway and thus may cause the same disease phenotype. We therefore hypothesized that identification of disease-associated pathways is critical to elucidate mechanisms underlying BD, and those pathways may be conserved within and across populations. To identify the disease-associated pathways, we developed a novel methodology that combines nominally significant evidence of genetic association with current knowledge of biochemical pathways, protein-protein interaction networks, and functional information of selected SNPs. Using this methodology, we searched for the disease-related pathways in two BD GWASs in Turkish and Japanese case-control groups. We found that 6 of the top 10 identified pathways in both populations were overlapping, even though there were few significantly conserved SNPs/genes within and between populations. The probability of random occurrence of such an event was 2.24E-39. These shared pathways were focal adhesion, MAPK signaling, TGF-β signaling, ECM-receptor interaction, complement and coagulation cascades, and proteasome pathways. Even though each individual has a unique combination of factors involved in their disease development, the targeted pathways are expected to be mostly the same. Hence, the identification of shared pathways between the Turkish and the Japanese patients using GWAS data may help further elucidate the inflammatory mechanisms in BD pathogenesis.

Entities:  

Mesh:

Year:  2014        PMID: 25227143      PMCID: PMC4402634          DOI: 10.1038/ejhg.2014.158

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  53 in total

Review 1.  Genomics and the multifactorial nature of human autoimmune disease.

Authors:  Judy H Cho; Peter K Gregersen
Journal:  N Engl J Med       Date:  2011-10-27       Impact factor: 91.245

2.  Functional analysis of HapMap SNPs.

Authors:  Ching-Ti Liu; Houwei Lin; Honghuang Lin
Journal:  Gene       Date:  2012-10-04       Impact factor: 3.688

3.  Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis.

Authors:  Rajkumar Noubade; Dimitry N Krementsov; Roxana Del Rio; Tina Thornton; Viswas Nagaleekar; Naresha Saligrama; Anthony Spitzack; Karen Spach; Guadalupe Sabio; Roger J Davis; Mercedes Rincon; Cory Teuscher
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

4.  Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.

Authors:  José Ma Ricart; Amparo Vayá; José Todolí; Javier Calvo; Piedad Villa; Amparo Estellés; Francisco España; Marisa Santaolaria; Dolores Corella; Justo Aznar
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

5.  Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.

Authors:  Ling Lu; Julie Wang; Feng Zhang; Yang Chai; David Brand; Xuehao Wang; David A Horwitz; Wei Shi; Song Guo Zheng
Journal:  J Immunol       Date:  2010-03-19       Impact factor: 5.422

6.  Systems and genome-wide approaches unite to provide a route to personalized medicine.

Authors:  Barbara E Stranger; Johan Björkegren; M Eileen Dolan; Marylyn D Ritchie
Journal:  Genome Med       Date:  2012-03-30       Impact factor: 11.117

7.  Pro-inflammatory cytokine and caspase-1 responses to pattern recognition receptor activation of neutrophils and dendritic cells in Behcet's disease.

Authors:  Filiz Türe-Özdemir; Aysin Tulunay; Mehmet Onur Elbasi; Imren Tatli; Anne-Marie Maurer; Gonca Mumcu; Haner Direskeneli; Emel Eksioglu-Demiralp
Journal:  Rheumatology (Oxford)       Date:  2013-01-15       Impact factor: 7.580

8.  Identifying SNP targeted pathways in partial epilepsies with genome-wide association study data.

Authors:  B Bakir-Gungor; B Baykan; S Ugur İseri; F N Tuncer; O U Sezerman
Journal:  Epilepsy Res       Date:  2013-03-14       Impact factor: 3.045

9.  A new methodology to associate SNPs with human diseases according to their pathway related context.

Authors:  Burcu Bakir-Gungor; Osman Ugur Sezerman
Journal:  PLoS One       Date:  2011-10-25       Impact factor: 3.240

10.  Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.

Authors:  Sergio E Baranzini; Nicholas W Galwey; Joanne Wang; Pouya Khankhanian; Raija Lindberg; Daniel Pelletier; Wen Wu; Bernard M J Uitdehaag; Ludwig Kappos; Chris H Polman; Paul M Matthews; Stephen L Hauser; Rachel A Gibson; Jorge R Oksenberg; Michael R Barnes
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more
  4 in total

1.  Transcriptome analysis reveals dynamic changes in coxsackievirus A16 infected HEK 293T cells.

Authors:  Jun Jin; Rujiao Li; Chunlai Jiang; Ruosi Zhang; Xiaomeng Ge; Fang Liang; Xin Sheng; Wenwen Dai; Meili Chen; Jiayan Wu; Jingfa Xiao; Weiheng Su
Journal:  BMC Genomics       Date:  2017-01-25       Impact factor: 3.969

Review 2.  Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

3.  pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks.

Authors:  Ege Ulgen; Ozan Ozisik; Osman Ugur Sezerman
Journal:  Front Genet       Date:  2019-09-25       Impact factor: 4.599

Review 4.  Current State of Precision Medicine in Primary Systemic Vasculitides.

Authors:  Erkan Demirkaya; Zehra Serap Arici; Micol Romano; Roberta Audrey Berard; Ivona Aksentijevich
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.